Showing results (341-350 of 357) with videos related to
Sort By:
Pageof 36
Cancer Research|July 15, 1997
Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograftH S Friedman, S P Johnson, Q Dong, et al.Medical and Pediatric Oncology|July 1, 1996
Successful treatment of childhood pilocytic astrocytomas metastatic to the leptomeninges with high-dose cyclophosphamideG McCowage, R Tien, R McLendon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor GroupW K Yung, M D Prados, R Yaya-Tur, et al.Cancer Chemotherapy and Pharmacology|January 29, 1999
Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferaseH S Friedman, A E Pegg, S P Johnson, et al.Neuro-Oncology|October 5, 2001
Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomasS Gururangan, L Cokgor, J N Rich, et al.Medical and Pediatric Oncology|June 1, 1996
Treatment of patients with pineoblastoma with high dose cyclophosphamideD M Ashley, D Longee, R Tien, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant gliomaH S Friedman, D M Kokkinakis, J Pluda, et al.International Journal of Radiation Oncology, Biology, Physics|March 8, 2000
Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapyG Akabani, I Cokgor, R E Coleman, et al.British Journal of Cancer|October 6, 2012
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patientsD A Reardon, J E Herndon, K B Peters, et al.Neurosurgical Focus|December 16, 2006
Phase II study of carboplatin (CBDCA) in progressive low-grade gliomasA Moghrabi, H S Friedman, D M Ashley, et al.Pageof 36